Literature DB >> 2536333

Protective and immunostimulating activity of a low dose of cyclophosphamide in the experimental infection of mice with foot-and-mouth disease virus.

E L Portiansky1, W M DiGirolamo, R P Laguens.   

Abstract

Administration to mice of a low, non-immunosuppressive dose of cyclophosphamide 4 days before infection with foot-and-mouth disease virus decreases viral replication, enhances the immune response against the virus and prevents pancreatic damage.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2536333     DOI： 10.1007/bf01990465

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  12 in total

1.  The occurrence of pancreatic lesions in adult mice infected with the virus of foot-and-mouth disease.

Authors:  H PLATT
Journal:  Virology       Date:  1959-11       Impact factor: 3.616

2.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

3.  The application of an in vitro cytotoxicity test to studies of the effects of drugs on the cellular immune response in mice. I. Primary response.

Authors:  L Fass; A Fefer
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

Review 4.  Conditioning regimens for marrow grafting.

Authors:  D W van Bekkum
Journal:  Semin Hematol       Date:  1984-04       Impact factor: 3.851

Review 5.  Cyclophosphamide: use in practice.

Authors:  M E Gershwin; E J Goetzl; A D Steinberg
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

6.  Metabolism of radioactive cyclophosphamide. Animal tests and clinical studies.

Authors:  E H Graul; E Schaumlöffel; H Hundeshagen; H Wilmanns; G Simon
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

7.  Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

8.  Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide.

Authors:  S H Kaufmann; H Hahn; T Diamantstein
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  Therapy of the murine plasmacytoma MOPC 104E: role of the immune response.

Authors:  R A Lubet; D E Carlson
Journal:  J Natl Cancer Inst       Date:  1978-09       Impact factor: 13.506

10.  Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.

Authors:  M Glaser
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307
View more
  2 in total

1.  The use of cyclophosphamide as an enhancer of the vaccine against foot-and-mouth disease.

Authors:  E L Portiansky; P H González; R P Laguens
Journal:  Experientia       Date:  1996-06-15

2.  Protective effect of lidocaine in the experimental foot-and-mouth disease pancreatitis.

Authors:  E L Portiansky; P H González
Journal:  Experientia       Date:  1995-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.